{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:14:20Z","timestamp":1784193260865,"version":"3.55.0"},"reference-count":35,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,8,30]],"date-time":"2007-08-30T00:00:00Z","timestamp":1188432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Microbiology and Immunology"],"published-print":{"date-parts":[[2007,10]]},"abstract":"<jats:p><jats:bold>Introduction:\u2002<\/jats:bold> Obligate anaerobes are closely involved in the pathogenesis of oral and focal infections. The objective of this study was to evaluate the susceptibility profiles of obligate anaerobes of oral origin to telithromycin (TLM), moxifloxacin (MXF), and other antibiotics that are commonly used in dentistry.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> The study sample comprised 172 obligate anaerobes isolated from the saliva of 43 adult volunteers. The minimum inhibitory concentrations (MICs) were determined by the agar dilution technique in <jats:italic>Brucella<\/jats:italic> agar medium supplemented with vitamin K, haemin and 5% (volume\/volume) laked sheep blood, and incubated under anaerobic conditions. The Clinical and Laboratory Standards Institute methodology was followed and its criteria were used for the qualitative interpretation of the results. The antibiotics evaluated were: amoxicillin (AMX), amoxicillin\u2010clavulanic acid (AMX\u2010CLA), clindamycin (CM), metronidazole (MTZ), azithromycin (AZM), TLM and MXF.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Resistance to AMX (MIC<jats:sub>90<\/jats:sub>\u2003\u200316\u2003mg\/l) was observed in 45.3% of the obligate anaerobes and resistance to CM (MIC<jats:sub>90<\/jats:sub>\u2003\u200316\u2003mg\/l) was found in 18.6%. All the isolates were sensitive to MTZ (MIC<jats:sub>90<\/jats:sub>\u2003=\u20031\u2003mg\/l) and 98.8% were sensitive to AMX\u2010CLA (MIC<jats:sub>90<\/jats:sub>\u2003=\u20032\u2003mg\/l). The MIC<jats:sub>90<\/jats:sub> values for AZM, TLM and MXF were 16, 8 and 2\u2003mg\/l, respectively.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Pathogenic, opportunistic and non\u2010pathogenic obligate anaerobes showed high percentages of resistance to AMX and CM, and high MIC values for AZM in the absence of recently administered antibiotics. MXF showed a higher activity than TLM, similar to that detected for AMX\u2010CLA and MTZ. In consequence, MXF could represent a possible alternative antimicrobial against obligate anaerobes of oral origin, particularly in those patients with allergy, intolerance or lack of response to AMX\u2010CLA or MTZ.<\/jats:p>","DOI":"10.1111\/j.1399-302x.2007.00359.x","type":"journal-article","created":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T04:11:10Z","timestamp":1188792670000},"page":"298-303","source":"Crossref","is-referenced-by-count":13,"title":["Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials"],"prefix":"10.1111","volume":"22","author":[{"given":"I.","family":"Tom\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Potel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Limeres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Diz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,30]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050465"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2003.0289"},{"key":"e_1_2_5_4_2","first-page":"363","article-title":"Consensus statement on antimicrobial treatment of odontogenic bacterial infections","volume":"9","author":"Bascones A","year":"2004","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960100568"},{"key":"e_1_2_5_6_2","first-page":"E70","article-title":"Antibiotic susceptibility of the bacteria causing odontogenic infections","volume":"11","author":"Bresc\u00f3 M","year":"2006","journal-title":"Med Oral Pathol Oral Cir Bucal"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.1.3.363"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540460058033"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10006-005-0646-0"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(99)00056-4"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2006.00924.x"},{"key":"e_1_2_5_12_2","volume-title":"The Sanford guide to antimicrobial therapy","author":"Gilbert DN","year":"2005"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.1963-1967.2003"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl121"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1997.9.6.415"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-302x.2004.00159.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-302X.2003.00078.x"},{"key":"e_1_2_5_18_2","first-page":"1691","article-title":"Telithromycin. Aventis Pharma","volume":"2","author":"Johnson AP","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2002.129535"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2005.00741.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2000.109639"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0902-0055.2001.00098.x"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.6.785"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00190-5"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.6.2.283"},{"key":"e_1_2_5_26_2","volume-title":"Manual of clinical microbiology","author":"Murray PR","year":"1999"},{"key":"e_1_2_5_27_2","volume-title":"Performance standards for antimicrobial susceptibility testing, 14th informational supplement","author":"NCCLS","year":"2004"},{"key":"e_1_2_5_28_2","volume-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria, approved standard","author":"NCCLS","year":"2004"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.Supplement_1.S110"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/107662903322762806"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.12.5794-5797.2003"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.4019-4021.2002"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1586\/14789072.2.5.685"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/16.Supplement_4.S304"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-051x.2000.027002079.x"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.4.467"}],"container-title":["Oral Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-302X.2007.00359.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-302X.2007.00359.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T14:04:33Z","timestamp":1697292273000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-302X.2007.00359.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,30]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1399-302X.2007.00359.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-302x.2007.00359.x","archive":["Portico"],"relation":{},"ISSN":["0902-0055","1399-302X"],"issn-type":[{"value":"0902-0055","type":"print"},{"value":"1399-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,30]]}}}